Profound Medical, A New and Innovative Way to Treat Prostate Cancer, CEO Clip Video

Vancouver, British Columbia--(Newsfile Corp. - June 24, 2016) - Steve Plymale, CEO of Profound Medical (TSXV: PRN), discusses the company's new and innovative way to treat prostate cancer.

If you cannot view the video above, please visit:
http://www.b-tv.com/profound-medical-ceo-clip/

Profound Medical is being featured on CBC's Documentary Channel Jun 27-Jul 10, 2016, Monday through Friday, throughout the day and evenings.

Profound Medical (TSXV: PRN)

Profound Medical Corp. was established in Toronto, Ontario, Canada in 2008. We are a medical device company that has commercialized a unique, Magnetic Resonance ("MR") guided ablation procedure for prostate care. With their minimally-invasive procedure called TULSA (Transurethral Ultrasound Ablation), they are able to ablate cancerous and non-cancerous prostate tissue, with millimeter precision in one session. Their team is determined to provide men with an option that ensures fast recovery, and reduces or eliminates the adverse side effects that typically come with other prostate cancer procedures. http://www.profoundmedical.com/

About CEO Clips:

CEO Clips is the largest library of publicly traded company CEO videos in the US and Canada.  These 90 second video profiles broadcast on national TV and are distributed online on top financial portals including: Thomson Reuters, BNN.ca, and Stockhouse.com.  They are also disseminated via a video news release to several financial portals including Globe Investor, OTC Markets, TMX Money, and The National Post.

BTV - Business Television/CEO Clip Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com